secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2022-12-09T23:59:59+00:00
Accession:  0001683168-22-008311
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences annual meeting adjourned on share-increase proposal; all directors elected
--------------------------------------------------------------------------------

- Elected all 7 director nominees: Borisenko, Callaway, Dastoor, Eisenberg, Kornberg, Logal, Vinogradov.
- Ratified Marcum LLP as independent auditor for FY2022 with 7.37M for, 58K abstained.
- Advisory vote on executive compensation approved: 4.23M for, 700K against, 66K abstain.
- Proposal 4 (increase authorized shares from 50M to 100M) adjourned to Dec 21; >80% of votes cast but not >50% of outstanding shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316822008311/0001683168-22-008311-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316822008311/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-008311

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer